Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Sacral Nerve Stimulation Devices Market, and What Factors Will Drive It?

The market for sacral nerve stimulation devices has seen a pronounced upsurge in the past few years. The market value, which stood at $1.33 billion in 2024, is projected to increase to $1.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. Several factors have contributed to this historical growth, including a higher frequency of urinary and fecal incontinence, improvements in neuromodulation technology, a heightened sense of awareness around non-invasive treatment options, beneficial reimbursement policies, an aging population, an increased occurrence of neurological disorders, and a rise in healthcare expenditure.

The market for sacral nerve stimulation devices is set to experience a significant surge in the coming years, with projections of it growing to a value of $2.28 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. This growth in the forecast period is primarily due to enhancement in reimbursement policies, wider approval of neuromodulation therapies, a rising incline for non-invasive or minimally invasive medical procedures, the investigation of sacral nerve stimulation devices, an increasing trend among patients and healthcare providers, favorable regulatory circumstances, and an increase in healthcare spending worldwide. Key trends within the forecast period encompass breakthroughs in miniaturization and implantable technologies, investigation of sacral nerve stimulation devices, the progression of external sacral nerve stimulation devices, patient education and consciousness, regulatory progress, market accessibility, spinal cord stimulation, or peripheral nerve stimulation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18458&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Sacral Nerve Stimulation Devices Market?

The augmenting occurrences of urological issues are anticipated to fuel the expansion of the sacral nerve stimulation devices market in the future. Such disorders incorporate a variety of health problems that impact the urinary tract, kidneys, bladder, and prostate, with varying durations from acute to chronic conditions. The genesis of urological disorders can originate from different causative agents, impacting the urinary tract and reproductive organs. Moreover, factors linked to lifestyle choices, such as a substandard diet, lack of hydration, and insufficient physical activity, might heighten the risk of developing renal calculi, a condition that causes severe pain in the urinary tract. Sacral nerve stimulation devices act as a minimally intrusive treatment alternative that can effectively control urological challenges, such as fecal and urinary incontinence. For example, data supplied by the National Institute of Diabetes and Digestive and Kidney Diseases in April 2024 indicate that in the United States, an average of 651,446 elders aged 65 or more, of which 212,875 are men and 438,572 are women got diagnosed with some form of urinary incontinence each year. Consequently, the escalating incidence of urological disorders is likely to stimulate the growth of the sacral nerve stimulation devices market.

Which Key Market Segments Comprise the Sacral Nerve Stimulation Devices Market and Drive Its Revenue Growth?

The sacral nerve stimulation devicesmarket covered in this report is segmented –

1) By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation

2) By Product: External Sacral Nerve Stimulation (SNS) Devices, Implantable Sacral Nerve Stimulation (SNS) Devices

3) By Age: Pediatrics, Adults, Geriatrics

4) By Application: Urinary Incontinence, Fecal Incontinence, Other Applications

5) By End User: Hospital, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:

1) By Electrical Muscle Stimulation: Surface Electrical Muscle Stimulation, Implantable Electrical Muscle Stimulation

2) By Transcutaneous Electrical Nerve Stimulation: Conventional TENS, Burst Mode TENS, Modulated TENS

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18458&type=smp

Which Areas Are Leading Regions in the Sacral Nerve Stimulation Devices Market Expansion Across the Globe?

North America was the largest region in the sacral nerve stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theSacral Nerve Stimulation Devices Market Direction?

Key players in the sacral nerve stimulation devices market are focusing on the creation of innovative offerings such as next-generation sacral neuromodulation appliances in order to improve patient results, boost device effectiveness, and minimize negative side effects. These next-generation tools are at the forefront of technology, offering improved command and efficiency in sacral nerve stimulation. For example, in February 2022, Medtronic plc. An Ireland-based company specializing in medical devices, introduced the InterStim X. This advanced device is devised for sacral neuromodulation therapy, primarily used in treating conditions like overactive bladder (OAB), chronic fecal incontinence, and non-obstructive urinary retention. InterStim X provides a long-lasting, personalized treatment that does not require recharging. Being recharge-free, the device offers patients prolonged therapy of a decade or more, ensuring improved comfort and adherence.

View the full report here:

https://www.thebusinessresearchcompany.com/report/sacral-nerve-stimulation-devices-global-market-report

How Is the Sacral Nerve Stimulation Devices Market Conceptually Defined?

A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It’s used to treat conditions such as urinary incontinence and an overactive bladder by regulating nerve activity. This technology aims to improve bladder function and quality of life for patients through targeted neurological intervention.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18458

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model